Login
Companies $SYK
$310.72 +$0.00 (0.0%) After hours
STRYKER CORP logo

STRYKER CORP

stryker.com

What Do They Do?

Sells surgical equipment and systems, patient-care and emergency products, vascular and brain-surgery devices, and joint-replacement and trauma implants to doctors, hospitals and other healthcare facilities.

How Do They Make Money?

Customers buy MedSurg and Neurotechnology products mainly at shipment or receipt; Orthopaedics sales follow a purchase order and notice that the product was used or implanted.

FY2025 revenue by reportable segment revenue
SegmentShareRevenue
MedSurg and Neurotechnology
Sold outright

55%
FY2022: 59%
Orthopaedics
Sold outright

45%
FY2022: 41%

Who Are Their Customers?

Products are sold through company-owned subsidiaries and branches and third-party dealers and distributors; most are marketed directly to doctors, hospitals and other healthcare facilities.

Do Revenues Turn Into Profits?

Yes. It kept 13 cents of every revenue dollar as net income in FY2025 and turned 17 cents into free cash flow.

Operating income, FY2025
19% of revenue
▲ +33% vs FY2024 ($3.7B, 16%)
Net income, FY2025
13% of revenue
▲ +8% vs FY2024 ($3B, 13%)
Free cash flow, FY2025
17% of revenue
▲ +23% vs FY2024 ($3.5B, 15%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
▲ +8%
vs $6.1B in Q3 FY2025
Net income
▼ −12%
vs $859M in Q3 FY2025
MedSurg and Neurotechnology: share of revenue vs 55.4% in Q3 FY2025
  • Oct 29, 2026 Stryker updated its full-year sales and earnings guidance It now expects organic net sales growth of 6.5% to 7.0% and adjusted net earnings per diluted share of $14.80 to $14.90.
  • Oct 6, 2026 Kevin Lobo will become Executive Chair as Spencer Stiles becomes CEO The handoff is effective January 1, 2027.

Growing. Revenue grew 47% in 4 years, from $17.1B in FY2021 to $25.1B in FY2025, about 10% a year.

Broader stroke and vascular treatments The earlier report describes minimally invasive products for acute ischemic stroke under Neurovascular; the latest also lists hemorrhagic stroke and venous thromboembolism treatments under Vascular.

Virtual care technology Medical's earlier description mentions clinical communication and workflow solutions; the latest adds an AI-assisted virtual care platform to its clinical communication products.

Revenue over time
MedSurg and Neurotechnology Orthopaedics Orthopaedics and Spine
$50B$25B$0

Who Do They Compete With?

Competes with Zimmer, Medtronic, Johnson & Johnson MedTech, CONMED, Karl, Olympus Optical, Smith & Nephew, Arthrex, STERIS, Baxter International, Zoll, Medline Industries, Ferno-Washington, Terumo, and Penumbra

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support